期刊中文名(ming):藥(yao)物保(bao)健(jian)和患者安(an)全ISSN:1179-1365
該(gai)雜志(zhi)國(guo)際簡稱:DRUG HEALTHC PATIENT,是由出(chu)版商(shang)Dove Medical Press出(chu)版的(de)(de)一本(ben)致力于發布--研(yan)究新(xin)成果(guo)的(de)(de)的(de)(de)專業(ye)學(xue)術(shu)期刊。主要(yao)發表刊登有創見(jian)的(de)(de)學(xue)術(shu)論文(wen)文(wen)章、行(xing)業(ye)最新(xin)科研(yan)成果(guo),扼要(yao)報道階(jie)段性研(yan)究成果(guo)和重要(yao)研(yan)究工作的(de)(de)最新(xin)進展,選載對學(xue)科發展起指導作用的(de)(de)綜述(shu)與專論,促(cu)進學(xue)術(shu)發展,為廣大(da)讀者服務。該(gai)刊是一本(ben)國(guo)際優秀雜志(zhi),在(zai)國(guo)際上有很(hen)高的(de)(de)學(xue)術(shu)影響力。
《Drug Healthcare And Patient Safety》是一本以(yi)English為(wei)(wei)主的(de)(de)(de)(de)開放(fang)獲取國際優秀(xiu)期(qi)刊(kan),中(zhong)文(wen)名稱藥物保健和(he)(he)患者安全,本刊(kan)主要(yao)出版(ban)、報道領(ling)(ling)域(yu)(yu)的(de)(de)(de)(de)研(yan)究(jiu)動(dong)態以(yi)及在該(gai)領(ling)(ling)域(yu)(yu)取得(de)的(de)(de)(de)(de)各方面的(de)(de)(de)(de)經驗和(he)(he)科研(yan)成(cheng)果,介紹該(gai)領(ling)(ling)域(yu)(yu)有關(guan)本專(zhuan)業(ye)(ye)的(de)(de)(de)(de)最(zui)新(xin)進展(zhan),探討行業(ye)(ye)發展(zhan)的(de)(de)(de)(de)思路和(he)(he)方法(fa),以(yi)促進學術信(xin)息交(jiao)流(liu),提高行業(ye)(ye)發展(zhan)。該(gai)刊(kan)已被(bei)國際權威數據(ju)庫SCIE收錄(lu),為(wei)(wei)該(gai)領(ling)(ling)域(yu)(yu)相關(guan)學科的(de)(de)(de)(de)發展(zhan)起到了良好的(de)(de)(de)(de)推動(dong)作(zuo)用,也得(de)到了本專(zhuan)業(ye)(ye)人員(yuan)的(de)(de)(de)(de)廣泛(fan)認(ren)可。該(gai)刊(kan)最(zui)新(xin)影響(xiang)因(yin)子為(wei)(wei)2.2,最(zui)新(xin)CiteScore 指數為(wei)(wei)4.1。
Drug Healthcare And Patient Safety covers a wide range of topics from basic research to clinical practice to policy development. It provides a valuable information exchange platform for healthcare professionals, drug developers, policy makers and patients worldwide. The journal focuses on how scientific research can improve the safety and effectiveness of drug use, reduce medical errors, and optimize patient care.
The journal encourages interdisciplinary research, including but not limited to pharmacoepidemiology, pharmacoeconomics, drug safety monitoring, medical technology evaluation, and the organization and management of health care services. It publishes research that not only contributes to understanding the mechanisms of action of drugs in different populations, but also addresses how to improve the delivery of healthcare services through a systematic approach. The audience is broad, including clinicians, pharmacists, caregivers, public health experts, healthcare administrators, and healthcare policy analysts. The articles published in the journal are rigorously peer-reviewed, ensuring that the research is scientific and practical, and has important implications for improving the quality of healthcare and patient safety.
按JIF指(zhi)標學科分(fen)區(qu) |
學科:HEALTH CARE SCIENCES & SERVICES
收錄子集:ESCI
分區:Q2
排名:83 / 174
百分位:
52.6% |
按JCI指標學科分區 |
學科:HEALTH CARE SCIENCES & SERVICES
收錄子集:ESCI
分區:Q3
排名:107 / 175
百分位:
39.14% |
JCR分區:JCR分(fen)區(qu)來自科(ke)睿唯(wei)安公司(si),JCR是(shi)一個(ge)獨特的(de)(de)(de)多學(xue)科(ke)期(qi)刊(kan)評價工具,為唯(wei)一提(ti)供基于引(yin)文數據(ju)的(de)(de)(de)統(tong)計信息(xi)的(de)(de)(de)期(qi)刊(kan)評價資源。每(mei)年(nian)發布的(de)(de)(de)JCR分(fen)區(qu),設置了254個(ge)具體學(xue)科(ke)。JCR分(fen)區(qu)根據(ju)每(mei)個(ge)學(xue)科(ke)分(fen)類按照期(qi)刊(kan)當年(nian)的(de)(de)(de)影響因子高低(di)將(jiang)期(qi)刊(kan)平(ping)均分(fen)為4個(ge)區(qu),分(fen)別為Q1、Q2、Q3和(he)Q4,各(ge)占25%。JCR分(fen)區(qu)中期(qi)刊(kan)的(de)(de)(de)數量是(shi)均勻分(fen)為四個(ge)部分(fen)的(de)(de)(de)。
學科類別 | 分區 | 排名 | 百分位 |
大類:Medicine 小類:Health Policy | Q2 | 105 / 310 |
66% |
大類:Medicine 小類:Pharmacology | Q3 | 171 / 313 |
45% |
該雜(za)志是一本(ben)國際優秀雜(za)志,在國際上有(you)較(jiao)高的學術影響力(li),行業關(guan)注度很高,已被國際權(quan)威數據庫SCIE收(shou)錄(lu),該雜(za)志在綜合專業領域專業度認可很高,對稿(gao)(gao)件內容的創新性和學術性要(yao)(yao)求(qiu)很高,作為一本(ben)國際優秀雜(za)志,一般投(tou)(tou)稿(gao)(gao)過審(shen)時間(jian)都較(jiao)長,投(tou)(tou)稿(gao)(gao)過審(shen)時間(jian)平均 16 Weeks ,如果(guo)想投(tou)(tou)稿(gao)(gao)該刊要(yao)(yao)做好時間(jian)安排(pai)。版面費(fei)不(bu)祥。該雜(za)志近兩年未被列入(ru)預警名單,建議(yi)您(nin)投(tou)(tou)稿(gao)(gao)。如您(nin)想了(le)解更(geng)多投(tou)(tou)稿(gao)(gao)政策及(ji)投(tou)(tou)稿(gao)(gao)方(fang)案,請咨詢客服。
若用戶需要出(chu)版服(fu)務,請聯系出(chu)版商。